The Princeton Alpha Management LP Boosts Stake in CME Group Inc (CME)

The Princeton Alpha Management LP Boosts Stake in CME Group Inc (CME)

Several other large investors have also recently modified their holdings of the company. Pekin Singer Strauss Asset Management IL boosted its stake in CME Group by 3.0% in the first quarter. Pekin Singer Strauss Asset Management IL now owns 13,628 shares of the financial services provider’s stock worth $1,619,000 after buying an additional 395 shares in the last quarter. HPM Partners LLC bought a new stake in CME Group during the first quarter worth about $212,000. Girard Partners LTD. boosted its stake in CME Group by 2.3% in the first quarter. Girard Partners LTD. now owns 2,234 shares of the financial services provider’s stock worth $265,000 after buying an additional 50 shares in the last quarter. Daiwa Securities Group Inc. boosted its stake in CME Group by 7.4% in the first quarter. Daiwa Securities Group Inc. now owns 9,450 shares of the financial services provider’s stock worth $1,123,000 after buying an additional 650 shares in the last quarter. Finally, Advisors Asset Management Inc. boosted its stake in CME Group by 52.9% in the first quarter. Advisors Asset Management Inc. now owns 21,098 shares of the financial services provider’s stock worth $2,506,000 after buying an additional 7,301 shares in the last quarter. 80.06% of the stock is currently owned by institutional investors and hedge funds.

Princeton Alpha Management LP boosted its position in CME Group Inc (NASDAQ:CME) by 60.6% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 12,978 shares of the financial services provider’s stock after buying an additional 4,898 shares during the period. Princeton Alpha Management LP’s holdings in CME Group were worth $1,542,000 as of its most recent filing with the SEC.

CME Group Inc (NASDAQ:CME) opened at 116.93 on Monday. The stock’s 50 day moving average price is $117.49 and its 200 day moving average price is $118.75. The stock has a market cap of $39.73 billion, a price-to-earnings ratio of 25.31 and a beta of 0.88. CME Group Inc has a 12-month low of $92.29 and a 12-month high of $127.60.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, April 27th. The financial services provider reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.20 by $0.02. CME Group had a return on equity of 7.28% and a net margin of 42.67%. The firm had revenue of $929 million during the quarter, compared to analyst estimates of $932.06 million. During the same quarter last year, the firm earned $1.15 EPS. CME Group’s quarterly revenue was down .5% on a year-over-year basis. Analysts forecast that CME Group Inc will post $4.86 EPS for the current fiscal year. The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 26th. Shareholders of record on Friday, June 9th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Wednesday, June 7th. This represents a $2.64 dividend on an annualized basis and a yield of 2.26%. CME Group’s dividend payout ratio (DPR) is presently 52.98%.

A number of equities research analysts recently issued reports on the stock. Deutsche Bank AG reissued a “buy” rating and issued a $133.00 price target (down previously from $134.00) on shares of CME Group in a research note on Monday, May 15th. Royal Bank of Canada dropped their price target on shares of CME Group from $133.00 to $130.00 and set an “outperform” rating on the stock in a research note on Monday, May 1st. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a report on Monday, March 20th. Finally, Jefferies Group LLC restated a “buy” rating and issued a $128.00 price objective on shares of CME Group in a report on Saturday, March 11th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company. CME Group has a consensus rating of “Hold” and a consensus price target of $116.88. In other CME Group news, Director Dennis Suskind sold 1,099 shares of the firm’s stock in a transaction that occurred on Friday, April 28th. The stock was sold at an average price of $115.29, for a total transaction of $126,703.71. Following the completion of the sale, the director now owns 5,000 shares in the company, valued at approximately $576,450. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Hilda Harris Piell sold 3,043 shares of CME Group stock in a transaction that occurred on Tuesday, March 14th. The stock was sold at an average price of $124.26, for a total value of $378,123.18. Following the completion of the transaction, the insider now owns 26,082 shares of the company’s stock, valued at approximately $3,240,949.32. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 16,907 shares of company stock valued at $2,009,182. 0.61% of the stock is owned by insiders.

About CME Group CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:CME”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for CME Group Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group Inc and related companies with our FREE daily email newsletter.

Related posts

Leave a Comment